酞胺***酮,反应停(原用作妊娠妇女的镇静药,但在20世纪60年代因发现会引起胎儿四肢畸形而被禁用) a sedative drug which was given to pregnant women until, in the 1960s, it was found to have prevented some babies from developing normal arms and legs
酞胺***酮,反应停(原为孕妇用药,被发现会导致胎儿四肢畸形后停用) Thalidomide is a drug which used to be given to pregnant women, before it was discovered that it resulted in babies being born with wrongly shaped arms and legs.
ADJ (由于母亲怀孕期间服用了反应停导致的)四肢畸形的 Thalidomide is used to describe someone whose arms and legs are wrongly shaped because their mother took thalidomide when she was pregnant.
...the special needs of thalidomide children. 四肢畸形儿童的特殊需要
Take, for example, thalidomide babies, parkinson's sufferers, autism or people who have cerebral palsy. 以反应停畸形儿、帕金森病患者、自闭症或患大脑性麻痹的人为例。
OBJECTIVE: To evaluate research progress and the usage of thalidomide in hematologic disease. 目的:评价沙利度胺在血液病中的研究进展及应用概况。
Moreover, anti-angiogenic effect of thalidomide in tumor tissues was investigated using this model. 应用此模型考察沙利度胺对肿瘤组织血管形成的影响。
Objective: To study the efficacy of combined capecitabine with thalidomide in treatment of advanced colorectal cancer and expression of thymidine phosphorylase in colorectal cancer tissue. 目的:探讨卡培他滨联合沙利度胺治疗晚期结直肠癌的近期疗效及癌组织胸苷磷酸化酶的表达。
Clinical study of low-dosage etanercept combined with thalidomide for treatment of ankylosing spondylitis 依那西普联合沙利度胺治疗强直性脊柱炎的临床研究
Effectiveness and Safety of Thalidomide for Treating Multiple Myeloma in China: A Meta-analysis 国内沙利度胺治疗多发性骨髓瘤疗效与安全性的Meta分析
Clinical research on low-dose thalidomide combined with dexamethasone for primarily diagnosed multiple myeloma 小剂量沙利度胺联合地塞米松治疗初诊多发性骨髓瘤的临床研究
Reversal Effect of A Novel N-sugar Substituted Thalidomide Analogue on Multidrug Resistant Human Nasopharyngeal Carcinoma Cells N糖基取代的沙利度胺新衍生物对人鼻咽癌细胞耐药逆转作用研究
Study on the Effects of Thalidomide on VEGF Expression in Patients with Rheumatoid Arthritis 沙利度胺对类风湿关节炎患者VEGF表达的影响
The clinical study of thalidomide combining with chemotherapy in treating of multiple myeloma 沙利度胺联合化疗治疗多发性骨髓瘤临床研究
Thalidomide combination transcatheter arterial chemoembolization in primary liver cancer 沙利度胺联合肝动脉栓塞化疗治疗中晚期原发性肝癌
Efficacy of Maintenance Therapy with Thalidomide for Multiple Myeloma 沙利度胺维持治疗多发性骨髓瘤疗效观察
Clinical research on middle-high dose Thalidomide Combined TACE treatment of primary liver cancer 中大剂量沙利度胺联合TACE治疗原发性肝癌临床研究
Effect of thalidomide combined with PC regimen on efficacy/ serum VEGF in patients with non-small cell lung cancer 沙利度胺联合PC方案对非小细胞肺癌患者疗效/血清VEGF的影响
Effect of thalidomide on MCP-1 in synovial joints of rats 沙利度胺对CIA鼠关节滑膜中MCP-1的影响
Effects of different doses of thalidomide in treating multiple myeloma 不同剂量沙利度胺对多发性骨髓瘤的疗效观察
Thalidomide in the Treatment of Myelodysplastic Syndromes Application 沙利度胺在骨髓增生异常综合征治疗中的应用
Controversial drug thalidomide does not improve survival for lung cancer patients, UK scientists say. 英国科学家称,有争议的药物萨立多胺并不能提高肺癌患者的生存机率。
Clinical Observation of Thalidomide for Treatment of Advanced Non-small-cell Lung Carcinoma 沙利度胺治疗中晚期非小细胞肺癌的临床观察
Experimental Study of Thalidomide Reverse Cancer Cachexia 沙利度胺逆转癌性恶病质的实验研究
Advances in Thalidomide Therapy for Idiopathic Myelofibrosis 沙利度胺治疗特发性骨髓纤维化的研究进展
Curative effect of Mitoxantrone plus Thalidomide and Dexamethasone on treatment of multiple myeloma 米托蒽醌联合沙利度胺、地塞米松治疗多发性骨髓瘤的疗效评价
Patients who took other treatments, like thalidomide and interferon-alpha, had no higher risk, researchers said. 研究者指出,患者采用其他的治疗药物,比如萨利多胺或干扰素,所带来的风险要小一些。
Scientists have discovered the primary mechanism by which thalidomide causes malformed limbs in developing embryos. 科学家已发现在胚胎发育过程中由萨立多胺所引发的畸形肢体的初步原因。
Cyclophosphamide thalidomide and dexamethasone combination chemotherapy in comparision with single-agent thalidomide in relapsed and refractory multiple myloma 含沙利度胺的联合化疗方案与沙利度胺单药对复发难治多发性骨髓瘤的疗效比较
Objective To assess the influences of thalidomide on function of endothelial cells in patients with hematologic tumors. 目的探讨沙利度胺对血液肿瘤患者内皮细胞功能的影响。
The Tumor Inhibitory Effect Study of Thalidomide on Malignant Melanoma Bearing Mice 反应停对荷恶性黑色素瘤小鼠的抑瘤作用研究
Objective: To observe the therapeutic effects and side-effects of thalidomide combined with arsenious oxide and retinoic acid for the treatment of low-risk myelodysplastic syndromes ( MDS). 目的:观察沙利度胺联合***和维甲酸治疗低危骨髓增生异常综合征(MDS)的疗效和不良反应。
Cloning would join the unsafe drug Thalidomide in the teratogenic hall of infamy. 克隆将作为致畸高手,与不安全药物反应停一样,臭名远扬。